HIGH-INCIDENCE OF MILD ACUTE MOUNTAIN-SICKNESS IN CONFERENCE ATTENDEES AT 10000 FOOT ALTITUDE

被引：34

作者：

DEAN, AG

YIP, R

HOFFMANN, RE

机构：

[1] Division of Surveillance and Epidemiologic Studies, Epidemiology Program Office, Centers for Disease Control, Atlanta, Georgia

[2] Division of Nutrition, Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control, Atlanta, Georgia

[3] Division of Disease Control and Environmental Epidemiology, Colorado Department of Health, Denver, Colorado

来源：

JOURNAL OF WILDERNESS MEDICINE | 1990年 / 1卷 / 02期

关键词：

ALTITUDE; MOUNTAIN SICKNESS; EPIDEMIOLOGY; EPIDEMIC; MEETINGS;

D O I：

10.1580/0953-9859-1.2.86

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

An epidemic of mild acute mountain sickness (AMS) occurred at a 4-day meeting of epidemiologists held at an altitude of 3000 m (9800 ft) in the Rocky Mountains of Colorado, USA. Questionnaires from 96% of the 105 attendees documented the following symptom frequencies: headache, 59%; shortness of breath, 59%; difficulty in sleeping, 45%; weakness or dizziness, 40%; and nausea, 12%. AMS, defined as three or more symptoms occurred in 42% of the respondents, and 90% had at least one symptom. One third felt the illness interfered with their concentration at the meeting, and 31% would not plan another meeting at this altitude, although only one person missed meeting sessions as a result of the AMS. AMS should be anticipated by those planning meetings of short duration at high altitude, and by physicians advising travelers to altitudes over 2000 m.

引用

页码：86 / 92

页数：7

共 16 条

[1]

Johnson T.S., Rock P.B., Current concepts: acute mountain sickness, N Eng J Med, 319, pp. 841-845, (1988)

[2]

High altitude sickness, Medical Letter, 30, pp. 89-90, (1988)

[3]

Montgomery A.B., Mills J., Luce J.M., Incidence of acute mountain sickness at intermediate altitude, JAMA, 261, pp. 732-734, (1989)

[4]

Hackett P.H., Rennie D., Levine H.D., The incidence, importance, and prophylaxis of acute mountain sickness, Lancet, 2, pp. 1149-1154, (1976)

[5]

Houston C.S., Incidence of acute mountain sickness: a study of winter visitors to six Colorado resorts, Am Alpine J, 27, pp. 162-165, (1985)

[6]

Forwand S.A., Landowne M., Follansbee J.N., Et al., Effect of acetazolamide on acute mountain sickness, N Eng J Med, 279, pp. 839-844, (1968)

[7]

Larson E.B., Roach R.C., Schoene R.B., Hornbein T.F, Acute mountain sickness and acetazolamide: clinical efficacy and effect on ventilation, JAMA, 248, pp. 328-332, (1982)

[8]

Ellsworth A.J., Larson D.B., Strickland D., A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis, Am J Med, 83, pp. 1024-1030, (1987)

[9]

Dean J.A., Dean A.G., Burton A., Dicker R., Epi Info computer programs for epidemiology, (1988)

[10]

Montgomery A., Luce J., Mills J., Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes, JAMA, 261, pp. 734-736, (1989)

← 1 2 →